Milan Kovacevic
Nessuna posizione attualmente
Storia della carriera di Milan Kovacevic
Precedenti posizioni note di Milan Kovacevic
Società | Posizione | Inizio | Fine |
---|---|---|---|
GENVEC INC | Direttore Tecnico/Scientifico/R&S | 21/07/2009 | - |
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - | - |
CANGENE CORPORATION | Direttore Tecnico/Scientifico/R&S | - | - |
SYNVISTA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Milan Kovacevic
University of Belgrade | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Canada | 2 |
Serbia, Repubblica di | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SYNVISTA THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
Cangene Corp.
Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
GenVec, Inc.
GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
- Borsa valori
- Insiders
- Milan Kovacevic
- Esperienza